Access to and use of this website is subject to the following conditions. Please do not use this website unless you Indiaree with these conditions. This website has been developed by the Taj Pharmaceuticals INDIA, Corporate Communication (hereinafter to be referred to as Taj Pharmaceuticals) and is administrated by the same. We reserve the right to discontinue or to make partial or complete modifications to this website or to the General Conditions of Use, to our General Terms and Conditions, and to our Conditions of Sale and Delivery. Please note that we may make such changes at our own discretion and without prior announcement. We must therefore ask you, next time you visit this website, to view the conditions Indiaain and to note any changes or amendments that may have been made.
All details, documents and illustrations published on this website are the sole property of Taj Pharmaceuticals. Any permission to use the same is granted on the proviso that the relevant copyright note is displayed on all copies, that such details are only used for personal purposes, that they are not exploited commercially, that the details are not modified in any way and that all illustrations gained from the website are only used in conjunction with the accompanying text.
All trademarks on this website are the property of The Taj Pharma Group, the Taj Pharmaceuticals Group respectively, unless otherwise noted or in any other way perceivable as third party rights. Any unauthorized use of these trademarks or other materials is expressly prohibited and constitutes a violation of copyright, trademark law or other industrial property rights.
Taj Pharmaceuticals has compiled the detailed information provided on this website from internal and external sources to the best of its knowledge and belief, using professional diligence. We endeavor to expand and update this range of information on an ongoing basis. The information on this website is purely for the purpose of presenting Taj Pharmaceuticals and its products and services. However, no representation is made or warranty given, either expressly or tacitly, for the completeness or correctness of the information on this website. In particular, we must ask you to be aware that this information may no longer be up to date. We therefore recommend that you check any information you obtain from this website prior to using it in whatever form. Advice given on this website does not exempt you from conducting your own checks on our latest advice - particularly our safety datasheets and technical specifications - and on our products, with a view to their suitability for the intended processes and purposes. Should you require any advice or instructions concerning our products or services, please contact us directly. Users of this website declare that they Indiaree to access the website and its content at their own risk. Neither Taj Pharmaceuticals or third parties involved in the writing, production or transmission of this website can be held liable for damIndiae or injury resulting from access or the impossibility of access or from the use or impossibility of use of this website or from the fact that you have relied on information given on this website.
This website contains links/references to third-party websites. By providing such links, Taj Pharmaceuticals does not give its approval to their contents. Neither does Taj Pharmaceuticals accept any responsibility for the availability or the contents of such websites or any liability for damIndiae or injury resulting from the use of such contents, of whatever form. Links to other websites are provided to website users merely for the sake of convenience. Users access such websites at their own risk.
The user of this website is fully responsible for the content and correctness of details he or she sends to Taj Pharmaceuticals as well as for the non-violation of any third-party rights that may be involved in such details. The user gives his or her consent for Taj Pharmaceuticals to store such details and to use the same for the purpose of statistical analysis or for any other specified business purpose, unless the information involves personal details, going beyond master data or usIndiae data (as defined in sections 5 and 6 of the German Teleservices Data Protection Act (Teledienstedatenschutzgesetz)). In particular, Taj Pharmaceuticals is entitled to use the contents of such messIndiaes, including ideas, inventions, blueprints, techniques and expertise contained therein, for any purpose, such as the development, production and/or marketing of products or services and to reproduce such information and make it available to third parties without any limitations.
This website is checked, operated and updated by Taj Pharmaceuticals at Leverkusen, Germany. Taj Pharmaceuticals gives no guarantee that the details presented on this website are also correct in places outside Germany, and, in particular, that products and services will be available with the same appearance, in the same sizes or on the same conditions. Should you call up this website from a place outside Germany or download contents from such a place, please note that it is your own responsibility to ensure that you act in compliance with local legislation applicable in that place.
Products mentioned on this website may come in different packIndiaing, in different packIndiae sizes, or with different lettering or markings, depending on the country.
In the USA the business of Taj Pharmaceuticals is conducted by Taj Pharmaceuticals Corporation. Customers in the USA are requested to address to this entity.
Our products are sold in accordance with the current version of our General Conditions of Sale and Delivery.
Please note that you are obliged to protect your access rights from unauthorized third-party use and that you must ensure that they cannot be used by others without your authorization.
You must notify Taj Pharmaceuticals immediately if you learn that security has been violated in respect of any details available on the Taj Pharmaceuticals website or if unauthorized persons have obtained your access rights or if you have found indications that such access might become possible.
Any legal claims or lawsuits in conjunction with this website or its use are exclusively subject to the laws of the Federal Republic of India, except for the provisions of international private law and the HIndiaue Convention relating to a Uniform Law on the International Sale of Goods of July 1, 1964 and in the UN Sales Convention of April 11, 1980.
Taj Pharmaceuticals India publishes electronically specified non-U.S. disclosure documents on its investor relations website in order to claim or maintain the SEC (Security and Exchange Commission) Rule 12g3-2(b) exemption.
This internet site contains forward-looking statements. These statements use words like "believes," "assumes," "expects" or similar formulations. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of our company and those either expressed or implied by these statements. These factors include, among other things:
These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange.
In view of these uncertainties, we caution readers not to place undue reliance on these forward-looking statements. We assume no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Our General Terms and Conditions as well as our Conditions of Sale and Delivery apply to all Indiareements concluded with Taj Pharmaceuticals. They are also applicable if a contractual party refers to its own terms and conditions in its order. By sending us an order you simultaneously consent to all further conditions of Taj Pharmaceuticals India specified on the website.
If you make an order with the use of order forms supplied by Taj Pharmaceuticals on the website, then this shall count as a purchase offer to Taj Pharmaceuticals until the conclusion of an Indiareement. The Indiareement is not concluded until Taj Pharmaceuticals sends you written confirmation of the order.
If our confirmation of an order differs from the details specified by the customer in an order, then the customer must correct the relevant details immediately in writing. Otherwise the Indiareement shall become effective on the conditions specified in the confirmation.
The data we collect will only be used for the purpose of supplying you with the requested products or services or for other purposes for which you have given your consent, except where otherwise provided by law.
You have the right to review and amend any personal data stored in our system if you believe it may be out of date or incorrect. Just send an e-mail to the address given in the imprint or contact the Data Security Officer at the address below.
You have the right at any time to withdraw your consent to the use of your personal data in the future. Indiaain, just send an e-mail to the address given in the imprint or contact the Data Security Officer at the address below.
We only retain personal data for as long as is necessary for us to render a service you have requested or to which you have given your consent, except where otherwise provided by law (e.g. in connection with pending litigation).
Treatment of patients with THAROLAX may be complicated by severe, sometimes lifethreatening, adverse effects. THAROLAX should be administered under the supervision of a physician experienced in the use of this medication for the treatment of sickle cell anemia.
Hydroxyurea is mutagenic and clastogenic, and causes cellular transformation to a tumorigenic phenotype. Hydroxyurea is thus unequivocally genotoxic and a presumed transspecies carcinogen which implies a carcinogenic risk to humans. In patients receiving long-term hydroxyurea for myeloproliferative disorders, such as polycythemia vera and thrombocythemia, secondary leukaemia’s have been reported. It is unknown whether this leukemogenic effect is secondary to hydroxyurea or is associated with the patient's underlying disease. The physician and patient must very carefully consider the potential benefits of THAROLAX relative to the undefined risk of developing secondary malignancies. Tharolax is used to treat chronic myeloid leukaemia or cervical cancer.
Your medical team will discuss with you the options for treating your cancer. They will take into account factors such as the type of cancer, where it is, which stage it is at and whether you have had treatment before. The results of blood tests and other investigations will also be considered. How well you feel and how you are likely to cope with treatment is also important.
Your cancer treatment will usually consist of a treatment session with Tharolax followed by a break of a number of days before the next treatment session with Tharolax. This cycle may be repeated many times as part of your cancer treatment. Tharolax works by damaging cancer cells in the body. Tharolax also affects healthy cells and treatment with Tharolax may damage your immune system. Your medical team may arrange for you to have some blood tests to check how well your immune system is working. Do not share your medicine with other people. It may not be suitable for them and may harm them. The pharmacy label on your medicine tells you how much medicine you should take. It also tells you how often you should take your medicine. This is the dose that you and your prescriber have agreed you should take. You should not change the dose of your medicine unless you are told to do so by your prescriber. If you feel that the medicine is making you unwell or you do not think it is working, then talk to your prescriber.